A nonionic water-insoluble surfactant used as cosurfactant in oral lipid-based formulation SEDDS and SMEDDS. Cosurfactant and solubilizer in topical dosage forms.
Names & synonyms
| USP NF Name | Propylene Glycol Mono and Dicaprylate NF |
|---|---|
| EP Name | / |
| UNII Code (FDA) | RT9P9S09QI |
| Preferred Substance Name (FDA) | PROPYLENE GLYCOL CAPRYLATE |
| Handbook of Pharmaceutical Excipients | Propylene glycol monocaprylate |
| Chemical description | Consists of propylene glycol esters of caprylic acid (C8), composed of mono- and diesters. |
Key characteristics
| Product form | Oily liquid |
|---|---|
| Viscosity (mPa.s) | 20 (20°C) |
| HLB | 6 |
Main functionalities
Solubilizer for poorly-soluble APIs and bioavailability enhancer. Co-surfactant in LFCS Type II (SEDDS) and Type III (SMEDDS) formulations.
Solubilizer and skin penetration enhancer. Co-surfactant for microemulsion in topical formulation.
Safety of use is inferred by precedence of use in approved pharmaceutical products.
Main formulation technologies
- Oral applications: self-emulsifying lipid formulation
- Topical emulgel, microemulsion and patches
Resources
Technical documentation
Brochures
-
Gattefosse brochure Selecting the best excipients to optimize drug delivery
-
Gattefosse brochure Lipid excipients for cannabinoid drug products
-
Gattefosse brochure Oral drug delivery with lipid excipients
-
Gattefosse Brochure Skin-Friendly Textures
-
Gattefosse brochure veterinary medicines with Lipid excipients
Associated content
Selecting penetration enhancers, for transdermal delivery
To overcome the skin barrier properties, many strategies exist, among which the use…
Patch, for controlled skin drug delivery
Adhesive patches are solid unit drug dosage forms, fixed to the skin to deliver a…
Excipients for solubility and bioavailability enhancement
Poor solubility, poor permeability, and pre-systemic elimination are factors that…